One page, the whole story.
Beta Drugs Limited
NSE: BETAHealthcare₹2,017 Cr SME
“Oncology top-10 masking downside with 37% profit CAGR.”
₹1,990.20
+2.15%+₹41.90 today
Day low ₹1,911.00Day high ₹2,000.00
Market view
our read, in one sentence, with the evidence one tap awayEODconviction recomputed 21:31No clear market view today
The signals we track (volume, delivery, price trend, deals, breadth and flows) aren't aligned for BETAtoday. That isn't bearish, just inconclusive.
Why now
today's active factors, delivery data and signals worth reviewingRSI Overbought
RSI indicates overbought conditions
Strongsignal strength
Safety checks
India-specific risk checks.
Business quality
the company itself, each lens scored and explained: a separate read from the Market Setup aboveEODfundamentals to FY26 Q352
A mixed fundamental picture
Four fundamentals lenses on the company itself: valuation, growth, returns & margins, and financial health, judged against the stock's sector. A separate read from the Market Setup above.
2 pass1 neutral1 fail
ValuationEXPENSIVE
0
Valuations look stretched
₹1,000 invested here buys about ₹15 of annual profit. A cheaper stock would buy more.
GrowthHIGH GROWTH
72
Strong revenue and profit growth
Returns & MarginsEXCELLENT
81
Excellent returns and margins
Financial HealthADEQUATE
53
Adequate balance sheet
Financials
income, balance sheet, cash flow, dividends and corporate actionsEODaudited to FY26Concalls
management commentary from earnings calls, summarisedEODlatest call 31 Dec '25Filings
exchange disclosures summarised as they are filed✦ AI summary: about 30s after the exchangePeers
how the stock stacks up against its closest listed comparablesEODprices end-of-dayData as of 19 Jun 2026, 9:31 pm